We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
1
0 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
2010
Completed
100.0%
No approval data available
- Toronto-based biotech company Radiant Biotherapeutics has named Deborah Geraghty, Ph.D., as President and Chief Executive Officer to lead the company's next phase of growth. - Dr. Geraghty brings over 20 years of financial, operational, and strategic experience in biopharmaceutical leadership, having previously served as President and CEO of Anokion SA. - The company also appointed Stefan Larson, Ph.D., as Chair of the Board of Directors and Ingmar Bruns, M.D., Ph.D., as Board Member to strengthen its leadership team. - The new leadership appointments position Radiant Biotherapeutics for strategic expansion under experienced biotechnology industry executives.
